We report a significant favourable effect of Metformin on glycemic control (HbA1c), glycemic variability (SD), insulin sensitivity, body weight and body composition (adiposity) as well as a cardiometabolic protective effect in Indian adolescents with type-1 diabetes, despite an increased dietary fat intake and reduced physical activity during lockdown. Here, INS is linked to type 1 diabetes mellitus.